Glucagon-like Peptide 1-Based Drugs and Pancreatic Safety

被引：1
作者：
Raschi, Emanuel [1 ]
Piccinni, Carlo [1 ]
Marchesini, Giulio [1 ]
机构：
[1] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
来源：
JAMA INTERNAL MEDICINE | 2013年 / 173卷 / 19期
关键词：
RISK;
D O I：
10.1001/jamainternmed.2013.8150
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1843 / 1843
页数：1
相关论文
共 50 条
[21]   Glucagon-like Peptide-1 receptor agonists for the prevention and treatment of Parkinson's disease [J].
Lee, Serene ;
Yin, Liyang ;
Xiao, Naomi ;
Rhee, Taeho Greg ;
Lo, Heidi K. Y. ;
Wong, Sabrina ;
Fox, Susan ;
Teopiz, Kayla ;
Lam, Bess Yin-Hung ;
Zheng, Yang Jing ;
Le, Gia Han ;
Mansur, Rodrigo B. ;
Rosenblat, Joshua D. ;
McIntyre, Roger S. .
CNS SPECTRUMS, 2025, 30 (01)
[22]   Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Study Based on the US FDA Adverse Event Reporting System Database [J].
Wu, Tingxi ;
Zhang, Yang ;
Shi, Yanfeng ;
Yu, Kefu ;
Zhao, Mei ;
Liu, Shangyi ;
Zhao, Zhigang .
CLINICAL DRUG INVESTIGATION, 2022, 42 (11) :965-975
[23]   Glucagon-Like Peptide-1 Receptor Agonist Medications Alter Outcomes of Spine Surgery [J].
Wiener, Joshua M. ;
Sanghvi, Parshva A. ;
Vlastaris, Katelyn ;
Mroz, Thomas ;
Belding, Jonathan ;
Kaelber, David C. ;
Olson, Thomas ;
Francis, Kevin P. ;
Adams, John S. ;
Bernthal, Nicholas ;
Sheppard, William L. .
SPINE, 2025, 50 (13) :871-880
[24]   Glucagon-like peptide-1 analogues and prevention of atrial fibrillation: clinical and mechanistic insights [J].
Ren, Qing-wen ;
Yiu, Kai-hang .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2025,
[25]   Patient education and monitoring recommendations for the use of glucagon-like peptide-1 receptor agonists [J].
Haines, Stuart T. .
JOURNAL OF FAMILY PRACTICE, 2009, 58 (09) :S44-S48
[26]   The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease [J].
Wang, Wenwen ;
Mei, Aihua ;
Qian, Hang ;
Li, Dongfeng ;
Xu, Hao ;
Chen, Jishun ;
Yang, Handong ;
Min, Xinwen ;
Li, Chunlei ;
Cheng, Li ;
Chen, Jun .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 :129-137
[27]   Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide [J].
Faurschou, A. ;
Knop, F. K. ;
Thyssen, J. P. ;
Zachariae, C. ;
Skov, L. ;
Vilsboll, T. .
ACTA DIABETOLOGICA, 2014, 51 (01) :147-150
[28]   Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire? [J].
Butler, P. C. ;
Matveyenko, A. V. ;
Dry, S. ;
Bhushan, A. ;
Elashoff, R. .
DIABETOLOGIA, 2010, 53 (01) :1-6
[29]   Suicidality among users of glucagon-like peptide-1 receptor agonists: An emerging signal? [J].
Lau, Darren ;
Gamble, John-Michael .
DIABETES OBESITY & METABOLISM, 2024, 26 (04) :1150-1156
[30]   Impact of Glucagon-Like Peptide 1 Receptor Agonists on Biochemical Markers of the Initiation of Atherosclerotic Process [J].
Hachula, Marcin ;
Kosowski, Michal ;
Ryl, Sabina ;
Basiak, Marcin ;
Okopien, Boguslaw .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
12345